Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,709 | -12,586 | -5,543 | -25,430 | -23,845 |
| Depreciation Amortization | 312 | 201 | 99 | 404 | 307 |
| Accounts payable and accrued liabilities | 198 | 1,621 | 1,132 | -2,234 | -1,662 |
| Other Working Capital | 288 | 2,959 | 2,167 | -11,483 | -5,510 |
| Other Operating Activity | 762 | -933 | -650 | 2,766 | 2,793 |
| Operating Cash Flow | $-16,149 | $-8,738 | $-2,795 | $-35,977 | $-27,917 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 18 | 18 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $18 | $18 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,350 | 2,600 | N/A | 10,000 | 10,000 |
| Common Stock Issued | 829 | 829 | 829 | 23,414 | 16,786 |
| Other Financing Activity | -100 | -100 | 0 | 0 | -177 |
| Financing Cash Flow | $11,079 | $3,329 | $829 | $33,414 | $26,609 |
| Exchange Rate Effect | N/A | N/A | 2 | N/A | N/A |
| Beginning Cash Position | 6,707 | 6,707 | 6,707 | 9,252 | 9,252 |
| End Cash Position | 1,637 | 1,298 | 4,743 | 6,707 | 7,962 |
| Net Cash Flow | $-5,070 | $-5,409 | $-1,964 | $-2,545 | $-1,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,149 | -8,738 | -2,795 | -35,977 | -27,917 |
| Capital Expenditure | N/A | N/A | N/A | -5 | N/A |
| Free Cash Flow | -16,149 | -8,738 | -2,795 | -35,982 | -27,917 |